- Home
- RETO vs BOLT Comparison
RETO vs BOLT Comparison
Compare RETO & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- BOLT
- Stock Information
- Founded
- RETO 1999
- BOLT 2015
- Country
- RETO China
- BOLT United States
- Employees
- RETO N/A
- BOLT N/A
- Industry
- RETO Multi-Sector Companies
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- RETO Consumer Discretionary
- BOLT Health Care
- Exchange
- RETO Nasdaq
- BOLT Nasdaq
- Market Cap
- RETO 19.9M
- BOLT 16.8M
- IPO Year
- RETO 2017
- BOLT 2021
- Fundamental
- Price
- RETO $3.50
- BOLT $0.40
- Analyst Decision
- RETO
- BOLT Hold
- Analyst Count
- RETO 0
- BOLT 5
- Target Price
- RETO N/A
- BOLT $1.13
- AVG Volume (30 Days)
- RETO 80.4K
- BOLT 146.3K
- Earning Date
- RETO 10-28-2024
- BOLT 05-13-2025
- Dividend Yield
- RETO N/A
- BOLT N/A
- EPS Growth
- RETO N/A
- BOLT N/A
- EPS
- RETO N/A
- BOLT N/A
- Revenue
- RETO $3,841,142.00
- BOLT $7,690,000.00
- Revenue This Year
- RETO N/A
- BOLT N/A
- Revenue Next Year
- RETO N/A
- BOLT $77.45
- P/E Ratio
- RETO N/A
- BOLT N/A
- Revenue Growth
- RETO N/A
- BOLT N/A
- 52 Week Low
- RETO $0.33
- BOLT $0.38
- 52 Week High
- RETO $7.10
- BOLT $1.48
- Technical
- Relative Strength Index (RSI)
- RETO 53.32
- BOLT 40.42
- Support Level
- RETO $3.35
- BOLT $0.38
- Resistance Level
- RETO $4.06
- BOLT $0.47
- Average True Range (ATR)
- RETO 0.64
- BOLT 0.04
- MACD
- RETO -0.22
- BOLT -0.00
- Stochastic Oscillator
- RETO 14.06
- BOLT 18.81
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.